Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus

Antimalarials are used to treat dermatomyositis (DM) and cutaneous lupus erythematosus (CLE). Although hydroxychloroquine (HCQ) is frequently used, addition of quinacrine (QC) has shown additional clinical effects when combined with HCQ. To quantify the effects of HCQ versus QC in suppressing secret...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Investig Dermatol Symp Proc
Asıl Yazarlar: Alves, Paul, Bashir, Muhammad M., Wysocka, Maria, Zeidi, Majid, Feng, Rui, Werth, Victoria P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5645024/
https://ncbi.nlm.nih.gov/pubmed/28941496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jisp.2016.11.001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller